CTLA4 and neoplasm: The results showed that the combination of cordycepin with CTLA-4 blockade significantly improved the efficacy and exhaustion state of infiltrating CD8+ T cells in the TME, reduced the number of Foxp3+ Tregs, and enhanced the anti-tumour immunity mediated by CD8+ T cells in the TME (Chen et al., 2023).